# Rapidly Evolving Cervical Dermatofibrosarcoma Protuberans With Deep Muscle Infiltration: A Rare and Aggressive Presentation

**Authors:** Oumaima Bouraqqadi, Sara Elloudi, Nawal Hammas, Nouha Boubekri, FatimaZahra Mernissi

PMC · DOI: 10.7759/cureus.84596 · Cureus · 2025-05-22

## TL;DR

A rare case of aggressive DFSP in the neck showed rapid growth and deep muscle invasion, responding well to imatinib when surgery was not possible.

## Contribution

Presents a rare, aggressive DFSP case with rapid progression and deep muscle infiltration, emphasizing the role of targeted therapy.

## Key findings

- The DFSP tumor showed rapid enlargement, necrosis, and deep muscle infiltration over two years.
- Imatinib treatment led to significant tumor regression when surgery was not feasible.
- The case highlights the importance of imaging and repeated histologic evaluation for atypical DFSP presentations.

## Abstract

Dermatofibrosarcoma protuberans (DFSP) is a rare, low-grade sarcoma that typically presents as a slow-growing cutaneous nodule or plaque. We report a highly unusual case of DFSP involving the neck, which demonstrated rapid enlargement, necrosis, and deep muscle infiltration. A 45-year-old man presented with a large, bleeding cervical tumor that had evolved over two years. Imaging revealed extensive involvement of the neck and shoulder musculature without distant metastasis. Histopathologic evaluation confirmed the diagnosis of DFSP. Given the tumor’s inoperability, treatment with imatinib was initiated, resulting in marked tumor regression. This case highlights an atypical presentation of DFSP in terms of both location and clinical behavior. It underscores the importance of repeated histologic assessment in the face of rapid progression, the role of imaging in surgical planning, and the value of targeted therapy when surgical options are limited.

## Linked entities

- **Chemicals:** imatinib (PubChem CID 5291)
- **Diseases:** Dermatofibrosarcoma protuberans (MONDO:0011934), DFSP (MONDO:0011934)

## Full-text entities

- **Diseases:** tumor (MESH:D009369), DFSP (MESH:D018223), metastasis (MESH:D009362), cervical tumor (MESH:D002583), bleeding (MESH:D006470), necrosis (MESH:D009336), sarcoma (MESH:D012509), Muscle Infiltration (MESH:D017254)
- **Chemicals:** imatinib (MESH:D000068877)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12181793/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12181793/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12181793/full.md

---
Source: https://tomesphere.com/paper/PMC12181793